Rizwan Afzal

7.9k total citations · 3 hit papers
34 papers, 3.7k citations indexed

About

Rizwan Afzal is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Rizwan Afzal has authored 34 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 7 papers in Surgery. Recurrent topics in Rizwan Afzal's work include Acute Myocardial Infarction Research (17 papers), Heart Failure Treatment and Management (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Rizwan Afzal is often cited by papers focused on Acute Myocardial Infarction Research (17 papers), Heart Failure Treatment and Management (9 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Rizwan Afzal collaborates with scholars based in Canada, United States and France. Rizwan Afzal's co-authors include Salim Yusuf, Shamir R. Mehta, Susan Chrolavicius, Philippe Gabríel Steg, Álvaro Avezum, Sanjit S. Jolly, Petr Widimský, Andrzej Budaj, Denis Xavier and Peggy Gao and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Rizwan Afzal

34 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial

2011 1.4k citations Sanjit S. Jolly, Salim Yusuf et al. The Lancet profile →
Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

2009 582 citations Shamir R. Mehta, Christopher B. Granger et al. New England Journal of Medicine profile →
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study

2003 531 citations Stefan D. Anker, Abdissa Negassa et al. The Lancet profile →

Peers

Countries citing papers authored by Rizwan Afzal

Since Specialization

Citations

This map shows the geographic impact of Rizwan Afzal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rizwan Afzal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rizwan Afzal more than expected).

Fields of papers citing papers by Rizwan Afzal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rizwan Afzal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rizwan Afzal. The network helps show where Rizwan Afzal may publish in the future.

Co-authorship network of co-authors of Rizwan Afzal

This figure shows the co-authorship network connecting the top 25 collaborators of Rizwan Afzal. A scholar is included among the top collaborators of Rizwan Afzal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rizwan Afzal. Rizwan Afzal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of Mean Onset of Motor and Sensory Block of Isobaric Ropivacaine and Hyperbaric Bupivacaine for Elective Caesarean Sections at Tertiary Care Hospital, Karachi. 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Rizwan Afzal	1
2	Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial breakdown → 2011 ·The Lancet ·Sanjit S. Jolly, Salim Yusuf, John A. Cairns, Kari Niemelä, Denis Xavier, Petr Widimský, Andrzej Budaj, Matti Niemelä, Vicent Valentín, Basil S. Lewis, Álvaro Avezum, Philippe Gabríel Steg, Sunil V. Rao, Peggy Gao, Rizwan Afzal, Campbell Joyner, Susan Chrolavicius, Shamir R. Mehta	1374
3	Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromes 2011 ·EuroIntervention ·Martial Hamon, Shamir R. Mehta, Philippe Gabríel Steg, David P. Faxon, Prafulla Kerkar, Hans‐Jürgen Rupprecht, Jean‐François Tanguay, Rizwan Afzal, Salim Yusuf	39
4	Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure 2010 ·PLoS ONE ·(unknown), Heiner C. Bucher, Inder S. Anand, (unknown), Leo C.C. Kum, Robert S. McKelvie, Rizwan Afzal, Michel White, Alain Nordmann	33
5	Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial 2010 ·American Heart Journal ·(unknown), Ron J.G. Peters, Salim Yusuf, Rizwan Afzal, Susan Chrolavicius, Martin O’Donnell, Shamir R. Mehta, (unknown), Jerzy Sacha, John W. Eikelboom	11
6	Mortality and morbidity following a major bleed in a registry population with acute ST elevation myocardial infarction 2010 ·Journal of Thrombosis and Thrombolysis ·(unknown), (unknown), Rizwan Afzal, (unknown), John W. Eikelboom, Madhu K. Natarajan	27
7	Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines 2009 ·Journal of the American College of Cardiology ·Sanjit S. Jolly, David P. Faxon, Keith A.A. Fox, Rizwan Afzal, William E. Boden, Petr Widimský, Philippe Gabríel Steg, Vicent Valentín, Andrzej Budaj, Christopher B. Granger, Campbell Joyner, Susan Chrolavicius, Salim Yusuf, Shamir R. Mehta	46
8	Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk 2009 ·American Heart Journal ·Campbell Joyner, Ron Peters, Rizwan Afzal, Susan Chrolavicius, Shamir R. Mehta, Keith A.A. Fox, Christopher B. Granger, Maria Grazia Franzosi, Marcus Flather, Andrzej Budaj, Jean‐Pierre Bassand, Salim Yusuf	23
9	Early versus Delayed Invasive Intervention in Acute Coronary Syndromes breakdown → 2009 ·New England Journal of Medicine ·Shamir R. Mehta, Christopher B. Granger, William E. Boden, Philippe Gabríel Steg, Jean‐Pierre Bassand, David P. Faxon, Rizwan Afzal, Susan Chrolavicius, Sanjit S. Jolly, Petr Widimský, Álvaro Avezum, Hans‐Jürgen Rupprecht, Jun Zhu, Jacques Col, Madhu K. Natarajan, (unknown), Keith A.A. Fox, Salim Yusuf	582
10	Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction—A prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial) 2009 ·American Heart Journal ·Mark A. Kotowycz, Tammy Cosman, (unknown), Rizwan Afzal, (unknown), Madhu K. Natarajan	71
11	Can we improve length of hospitalization in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention? 2009 ·Canadian Journal of Cardiology ·Mark A. Kotowycz, (unknown), Rizwan Afzal, Madhu K. Natarajan	21
12	Relationships Between Plasma Levels of Matrix Metalloproteinases and Neurohormonal Profile in Patients with Heart Failure 2008 ·European Journal of Heart Failure ·Andrew T. Yan, Raymond T. Yan, Francis G. Spinale, Rizwan Afzal, Himali R. Gunasinghe, Robert E. Stroud, Robert S. McKelvie, Peter P. Liu	28
13	The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study 2008 ·Nature Clinical Practice Cardiovascular Medicine ·(unknown), Denis Xavier, Prem Pais, Alben Sigamani, Janice Pogue, Rizwan Afzal, Salim Yusuf	11
14	Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 2007 ·Journal of the American College of Cardiology ·Shamir R. Mehta, Christopher B. Granger, John W. Eikelboom, Jean‐Pierre Bassand, Lars Wallentin, David P. Faxon, Ron J.G. Peters, Andrzej Budaj, Rizwan Afzal, Susan Chrolavicius, Keith A.A. Fox, Salim Yusuf	166
15	Glucose-Insulin-Potassium Therapy in Patients With ST-Segment Elevation Myocardial Infarction 2007 ·JAMA ·Rafael Díaz, Abhinav Goyal, Shamir R. Mehta, Rizwan Afzal, Denis Xavier, Prem Pais, Susan Chrolavicius, Jun Zhu, Khawar Kazmi, Lisheng Liu, Andrzej Budaj, Mohammad Zubaid, Álvaro Avezum, Mikhail Ruda, Salim Yusuf	121
16	Plasma Matrix Metalloproteinase-9 Level Is Correlated With Left Ventricular Volumes and Ejection Fraction in Patients With Heart Failure 2006 ·Journal of Cardiac Failure ·Andrew T. Yan, Raymond T. Yan, Francis G. Spinale, Rizwan Afzal, Himali R. Gunasinghe, Malcolm Arnold, Catherine Demers, Robert S. McKelvie, Peter P. Liu	64
17	A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions 2005 ·American Heart Journal ·Madhu K. Natarajan, James L. Velianou, Alexander G.G. Turpie, Shamir R. Mehta, (unknown), David Goodhart, Rizwan Afzal, Jeffrey S. Ginsberg	12
18	1049-114 Increasing atrial natriuretic peptide over time independently predicts higher short-term mortality and morbidity in heart failure 2004 ·Journal of the American College of Cardiology ·Raymond T. Yan, Rizwan Afzal, Robert S. McKelvie	1
19	A randomized comparison of dalteparin versus unfractionated heparin during percutaneous coronary interventions 2003 ·Journal of the American College of Cardiology ·Madhu K. Natarajan, (unknown), (unknown), James L. Velianou, Shamir R. Mehta, Rizwan Afzal, (unknown), Jeffrey S. Ginsberg	1
20	Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study breakdown → 2003 ·The Lancet ·Stefan D. Anker, Abdissa Negassa, Andrew J.S. Coats, Rizwan Afzal, Philip A. Poole‐Wilson, Jay N. Cohn, Salim Yusuf	531

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact